Updated June 18, 2024

Adding to the expiring BPA and IDIQ contracts posted yesterday, a couple dozen expiring tasks and contracts have been added below. We hope to see many of you at the sold-out FDA ODT & Centers: New Acquisition Strategy, Opportunity Roadmap event this afternoon.


Added June 17, 2024

The final quarter of FY 2024 promises to be a busy one, but many are looking ahead. The OS AI team has received multiple inquiries from forward-looking Food and Drug Administration focused companies researching potential task orders and contracts that expire and/or will be competed in fiscal year 2025.

A primary topic of the day at tomorrow’s FDA ODT & Centers:New Acquisition Strategy,Opportunity Roadmap FY24 & FY25 event (There are a few tickets left) will undoubtedly be the potential for a multiple-billion dollar multiple-award Enterprise IT Application Development BPA (see the recent RFI FDA-RFI-75F40124Q00156  here)

Several IDIQ and BPA contracts are set to (potentially) expire and/or be recompeted in FY 2025 are included below.

OS AI Note – Dance Lightly.Do know that some of these potential requirements will NOT end up being recompeted for any number of reasons (e.g., contract consolidation, extension, cancellation, etc). And many of these contracts set to expire in early FY 2025 are already in process. Regardless, this list can serve as a foundation as you build out your pipeline and start to have teaming discussions.   

And, here are a couple dozen expiring tasks and contracts that companies will be evaluating. NOTE: FDA likes its IDIQs and BPA at a level unlike any other Federal agency. We have tried to only include tasks here that were competed or awarded under a multiple-award BPA

Related

Ad



Not Yet a Premium Partner/Sponsor? Learn more about the OS AI Premium Corporate and Individual Plans here. Plans start at $250 annually.

How useful was this post?

Click on a star to rate it!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Reply